|
1
|
Lowe KA, Chia VM, Taylor A, O'Malley C,
Kelsh M, Mohamed M, Mowat FS and Goff B: An international
assessment of ovarian cancer incidence and mortality. Gynecol
Oncol. 130:107–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mayr D, Kanitz V, Amann G, Engel J, Burges
A, Löhrs U and Diebold J: HER-2/neu amplification in ovarian
tumours: A comprehensive immunohistochemical and FISH analysis on
tissue microarrays. Histopathology. 48:149–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chao WR, Lee MY, Lin WL, Chen CK, Lin JC,
Koo CL, Sheu GT and Han CP: HER2 amplification and overexpression
are significantly correlated in mucinous epithelial ovarian cancer.
Hum Pathol. 45:810–816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li C, Ao J, Fu J, Lee DF, Xu J, Lonard D
and O'Malley BW: Tumor-suppressor role for the SPOP ubiquitin
ligase in signal-dependent proteolysis of the oncogenic
co-activator SRC-3/AIB1. Oncogene. 30:4350–4364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geng C, He B, Xu L, Barbieri CE, Eedunuri
VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C, et al: Prostate
cancer-associated mutations in speckle-type POZ protein (SPOP)
regulate steroid receptor coactivator 3 protein turnover. Proc Natl
Acad Sci USA. 110:6997–7002. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mani RS: The emerging role of speckle-type
POZ protein (SPOP) in cancer development. Drug Discovery Today.
19:1498–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim MS, Je EM, Oh JE, Yoo NJ and Lee SH:
Mutational and expressional analyses of SPOP, a candidate tumor
suppressor gene, in prostate, gastric and colorectal cancers.
APMIS. 121:626–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Theurillat JP, Udeshi ND, Errington WJ,
Svinkina T, Baca SC, Pop M, Wild PJ, Blattner M, Groner AC, Rubin
MA, et al: Ubiquitylome analysis identifiesdysregulation of
effector substrates inSPOP-mutant prostate cancer. Science.
346:85–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hopman AH, Ramaekers FC, Raap AK, Beck JL,
Devilee P, van der Ploeg M and Vooijs GP: In situ hybridization as
a tool to study numerical chromosome aberrations in solid bladder
tumors. Histochemistry. 89:307–316. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aravidis C, Panani AD, Kosmaidou Z,
Thomakos N, Rodolakis A and Antsaklis A: Detection of numerical
abnormalities of chromosome 9 and p16/CDKN2A gene alterations in
ovarian cancer with fish analysis. Anticancer Res. 32:5309–5313.
2012.PubMed/NCBI
|
|
11
|
Puig S, Ruiz A, Lázaro C, Castel T, Lynch
M, Palou J, Vilalta A, Weissenbach J, Mascaro JM and Estivill X:
Chromosome 9p deletions in cutaneous malignant melanoma tumors: The
minimal deleted region involves markers outside the p16 (CDKN2)
gene. Am J Hum Genet. 57:395–402. 1995.PubMed/NCBI
|
|
12
|
Caldas C, Hahn SA, da Costa LT, Redston
MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern
SE: Frequent somatic mutations and homozygous deletions of the p16
(MTS1) gene in pancreatic adenocarcinoma. Nat Genet. 8:27–32. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Williamson MP, Elder PA, Shaw ME, Devlin J
and Knowles MA: p16 (CDKN2) is a major deletion target at 9p21 in
bladder cancer. Hum Mol Genet. 4:1569–1577. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Panani AD, Maliaga K, Babanaraki A and
Bellenis I: Numerical abnormalities of chromosome 9 and p16CDKN2A
gene deletion detected by FISH in non-small cell lung cancer.
Anticancer Res. 29:4483–4487. 2009.PubMed/NCBI
|
|
15
|
Li G, Ci W, Karmakar S, Chen K, Dhar R,
Fan Z, Guo Z, Zhang J, Ke Y, Wang L, et al: SPOP promotes
tumorigenesis by acting as a key regulatory hub in kidney cancer.
Cancer Cell. 25:455–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kato H, Arakawa A, Suzumori K, Kataoka N
and Young SR: FISH analysis of BRCA1 copy number in
paraffin-embedded ovarian cancer tissue samples. Exp Mol Pathol.
76:138–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhuang M, Calabrese MF, Liu J, Waddell MB,
Nourse A, Hammel M, Miller DJ, Walden H, Duda DM, Seyedin SN, et
al: Structures of SPOP-substrate complexes: Insights into molecular
architectures of BTB-Cul3 ubiquitin ligases. Mol Cell. 36:39–50.
2009. View Article : Google Scholar : PubMed/NCBI
|
